Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank86
3Y CAGR+20.9%
5Y CAGR+16.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+20.9%/yr
Annual compound
5Y CAGR
+16.4%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | +16.0% |
| 2024 | 0.01 | +61.3% |
| 2023 | 0.01 | -5.5% |
| 2022 | 0.01 | +4.1% |
| 2021 | 0.01 | +16.0% |
| 2020 | 0.01 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | -100.0% |
| 2016 | 4.22 | - |